Zhejiang Orient Gene Biotech Co Ltd (688298) - Total Liabilities

Latest as of September 2025: CN¥1.01 Billion CNY ≈ $148.51 Million USD

Based on the latest financial reports, Zhejiang Orient Gene Biotech Co Ltd (688298) has total liabilities worth CN¥1.01 Billion CNY (≈ $148.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Zhejiang Orient Gene Biotech Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Zhejiang Orient Gene Biotech Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Zhejiang Orient Gene Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Zhejiang Orient Gene Biotech Co Ltd (688298) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Zhejiang Orient Gene Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Orient Gene Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
CARE Ratings Limited NSE:CARERATING	India	Rs1.65 Billion
LX Semicon Co. Ltd KQ:108320	Korea	₩357.15 Billion
Guangdong Piano Customized Furniture Co Ltd SHE:002853	China	CN¥540.43 Million
Mühlbauer Holding AG XETRA:MUB	Germany	€315.43 Million
Guangzhou Pearl River Industrial Development Co Ltd SHG:600684	China	CN¥842.36 Million
First Sensor AG F:SIS	Germany	€42.02 Million
Universal Health Realty Income Trust NYSE:UHT	USA	$415.96 Million
Grupa Azoty S.A. WAR:ATT	Poland	zł19.27 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Zhejiang Orient Gene Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688298 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Orient Gene Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)

The table below shows the annual total liabilities of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.30 Billion ≈ $190.69 Million	-9.89%
2023-12-31	CN¥1.45 Billion ≈ $211.63 Million	-39.25%
2022-12-31	CN¥2.38 Billion ≈ $348.38 Million	+14.01%
2021-12-31	CN¥2.09 Billion ≈ $305.57 Million	+86.14%
2020-12-31	CN¥1.12 Billion ≈ $164.16 Million	+944.66%
2019-12-31	CN¥107.38 Million ≈ $15.71 Million	-17.15%
2018-12-31	CN¥129.62 Million ≈ $18.97 Million	+6.94%
2017-12-31	CN¥121.20 Million ≈ $17.74 Million	-14.82%
2016-12-31	CN¥142.28 Million ≈ $20.82 Million	--

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$561.69 Million

CN¥3.84 Billion CNY

Market Cap Rank

#11628 Global

#3292 in China

Share Price

CN¥19.04

Change (1 day)

+0.11%

52-Week Range

CN¥17.47 - CN¥29.94

All Time High

CN¥221.47